Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3)

Pharmacological Research

Volumn 56, Issue 6, 2007, Pages 468-473

  Hong, Soon Sun ^a   Seo, Kisoo ^b   Lim, Sung Chul ^b   Han, Hyo Kyung ^b  

^a Inha University School of Medicine   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Cellular uptake; Flavonoids; Human organic anion transporter 1 (hOAT1); Human organic anion transporter 3 (hOAT3); Inhibition

Indexed keywords

4 AMINOHIPPURIC ACID; AURANTIIN; FLAVONOID; MORIN; NARINGENIN; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; QUERCETIN; SILIBININ;

ARTICLE; CELL TRANSPORT; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; CELL LINE; DOGS; DRUG INTERACTIONS; ESTRONE; FLAVONOIDS; HUMANS; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; POLYCYCLIC HYDROCARBONS, AROMATIC; TRANSFECTION;

EID: 36249009108     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.08.007     Document Type: Article

References (35)

1. Cassileth B.R., and Deng G. Complementary and alternative therapies for cancer. Oncologist 9 (2004) 80-89
2. Tindle H.A., Davis R.B., Phillips R.S., and Eisenberg D.M. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 11 (2005) 42-49
3. Sparreboom A., Cox M.C., Acharya M.R., and Figg W.D. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22 (2004) 2489-2503
4. Cermak R., and Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr Drug Metab 7 (2006) 729-744
5. Moon Y.J., Wang X., and Morris M.E. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20 (2006) 187-210
6. Beecher G.R. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133 (2003) 3248S-3254S
7. Yao L.H., Jiang Y.M., Shi J., Tomas-Barberan F.A., Datta N., Singanusong R., et al. Flavonoids in food and their health benefits. Plant Foods Hum Nutr 59 (2004) 113-122
8. Hertog M.G.L., Hollmann P.C.H., and van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines and fruit juices. J Agric Food Chem 41 (1993) 1242-1246
9. Visioli F., and Hagen T.M. Nutritional strategies for healthy cardiovascular aging: focus on micronutrients. Pharmacol Res 55 (2007) 199-206
10. Hodek P., Trefil P., and Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139 (2002) 1-21
11. Morris M.E., and Zhang S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 78 (2006) 2116-2130
12. Brand W., Schutte M.E., Williamson G., van Zanden J.J., Cnubben N.H., Groten J.P., et al. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 60 (2006) 508-519
13. Dresser G.K., Bailey D.G., Leake B.F., Schwarz U.I., Dawson P.A., Freeman D.J., et al. Fruit juices inhibit organic anion-transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 71 (2002) 11-20
14. Satoh H., Yamashita F., Tsujimoto M., Murakami H., Koyabu N., Ohtani H., et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 33 (2005) 518-523
15. Fuchikami H., Satoh H., Tsujimoto M., Ohdo S., Ohtani H., and Sawada Y. Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 34 (2006) 577-582
16. Wang X., Wolkoff A.W., and Morris M.E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab Dispos 33 (2005) 1666-1672
17. Wang Q., and Morris M.E. Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo. Drug Metab Dispos 35 (2007) 201-208
18. Burckhardt B.C., and Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146 (2003) 95-158
19. Robertson E.E., and Rankin G.O. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion. Pharmacol Ther 109 (2006) 399-412
20. Motohashi H., Sakurai Y., Saito H., Masuda S., Urakami Y., Goto M., et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13 (2002) 866-874
21. Overbosch D., Van Gulpen C., Hermans J., and Mattie H. The effect of probenecid on the renal tubular excretion of benzylpenicillin. Br J Clin Pharmacol 25 (1988) 51-58
22. Hedaya M.A., Elmquist W.F., and Sawchuk R.J. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers. Pharm Res 7 (1990) 411-417
23. Gwak H.S., Oh J.H., and Han H.K. Effects of nonsteroidal anti-inflammatory drugs on the pharmacokinetics and elimination of aciclovir in rats. J Pharm Pharmacol 57 (2005) 393-398
24. Aslamkhan A.G., Han Y.H., Yang X.P., Zalups R.K., and Pritchard J.B. Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells. Mol Pharmacol 63 (2003) 590-596
25. Hou Y.C., Chao P.D.L., Ho H.J., Wen C.C., and Hsiu S.L. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J Pharm Pharmacol 55 (2002) 199-203
26. Ho E.S., Lin D.C., Mendel D.B., and Cihlar T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11 (2000) 383-393
27. Takeda M., Khamdang S., Narikawa S., Kimura H., Kobayashi Y., Yamamoto T., et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther 300 (2002) 918-924
28. Takeda M., Khamdang S., Narikawa S., Kimura H., Hosoyamada M., Cha S.H., et al. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther 302 (2002) 666-671
29. Lacy S.A., Hitchcock M.J., Lee W.A., Tellier P., and Cundy K.C. Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicol Sci 44 (1998) 97-106
30. Lalezari J.P., Stagg R.J., Kuppermann B.D., Holland G.N., Kramer F., Ives D.V., et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 126 (1997) 257-263
31. Mulato A.S., Ho E.S., and Cihlar T. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J Pharmacol Exp Ther 295 (2000) 10-15
32. Bennett W.M., Henrich W.L., and Stoff J.S. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 28 1 Suppl. 1 (1996) S56-S62
33. Bjorkman D. Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. Am J Med 105 (1998) 17S-21S
34. Apiwattanakul N., Sekine T., Chairoungdua A., Kanai Y., Nakajima N., Sophasan S., et al. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. Mol Pharmacol 55 (1999) 847-854
35. Hasannejad H., Takeda M., Taki K., Shin H.J., Babu E., Jutabha P., et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 308 (2004) 1021-1029